[The evaluation of cilazapril efficacy in patients with stable arterial hypertension (a randomized study)].
34 patients with stable arterial hypertension (AH) were randomized by mean arterial pressure (MAP), end-diastolic LV volume and cardiac output in a study of cilazapril efficacy in a dose 2.5 and 5 mg/day. Antihypertensive effect in the majority of patients with MAP 120-135 and 136-150 mm Hg was insufficient (diastolic pressure > 94 mm Hg). Dose-effect action on hemodynamics was absent. Hemodynamic benefits were noted in patients with end diastolic LV volume > 5.0-5.7 cm.
D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D017315:Cilazapril / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010919:Placebos; D016277:Ventricular Function, Left / Q000187:drug effects
D000959:Antihypertensive Agents; D010919:Placebos; D017315:Cilazapril
Otsenka éffektivnosti tsilazaprila u bol'nykh stabil'noĭ arterial'noĭ gipertonieĭ (randomizirovannoe issledovanie).